Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 3/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.43 |
| ▸ | FNTA | P49354 | 1/20 | 0.39 |
| ▸ | FNTB | P49356 | 1/20 | 0.39 |
| ▸ | CTSK | P43235 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14482060 | 1.00 | GRIK1 (0.43) | GRIK1GRIK2FNTAFNTBCTSK | |
| SCHEMBL2438781 | 0.80 | GRIK1 (0.38) | GRIK1GRIK2FNTAFNTB | |
| SCHEMBL2438783 | 0.80 | GRIK1 (0.38) | GRIK1GRIK2FNTAFNTB | |
| SCHEMBL3644901 | 0.78 | GRIK1 (0.46) | GRIK1GRIK2CTSK | |
| SCHEMBL11396319 | 0.78 | GRIK1 (0.46) | GRIK1GRIK2CTSK | |
| SCHEMBL2591191 | 0.77 | GRIK1 (0.44) | GRIK1GRIK2FNTAFNTB | |
| SCHEMBL724992 | 0.73 | FNTA (0.65) | FNTAFNTBKDM4EATMPOLB | |
| SCHEMBL940703 | 0.73 | FNTA (0.65) | FNTAFNTBKDM4EATMPOLB | |
| SCHEMBL11672889 | 0.73 | GRIK1 (0.39) | GRIK1GRIK2FNTAFNTB | |
| SCHEMBL15639480 | 0.72 | FNTA (0.68) | FNTAFNTBKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8809256-B2 | 2-hydroxy-6-methyl-heptane derivatives as perfuming ingredients | FIRMENISH SA (CH) | 2014-08-19 | — | — | US | disclosed |
| EP-2563752-B1 | 2-HYDROXY-6-METHYL-HEPTANE DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH & CIE (CH) | 2014-01-15 | — | — | EP | disclosed |
| EP-2563752-A1 | 2-HYDROXY-6-METHYL-HEPTANE DERIVATIVES AS PERFUMING INGREDIENTS | Firmenich SA (CH) | 2013-03-06 | — | — | EP | disclosed |
| US-20130011353-A1 | 2-HYDROXY-6-METHYL-HEPTANE DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2013-01-10 | — | — | US | disclosed |
| WO-2011135487-A1 | 2-HYDROXY-6-METHYL-HEPTANE DERIVATIVES AS PERFUMING INGREDIENTS | FIRMENICH SA (CH) | 2011-11-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130011353-A1 | 2-HYDROXY-6-METHYL-HEPTANE DERIVATIVES AS PERFUMING INGREDIENTS | HTR3C, HMOX2, CYP8B1 | GRIK1 3227/4885GRIK2 2030/4885FNTA 2227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.